Comparison between propranolol 2% cream versus timolol 0.5% gel for the treatment of Kaposi sarcoma.

Giorgio CMR, Licata G, Briatico G, Babino G, Fulgione E, Gambardella A, Alfano R, Argenziano G. Comparison between propranolol 2% cream versus timolol 0.5% gel for the treatment of Kaposi sarcoma. Int J Dermatol. 2021 May; 60(5):631-633.

View in: PubMed

subject areas

Adrenergic beta-Antagonists
Humans
Propranolol
Sarcoma, Kaposi
Skin Neoplasms
Timolol

authors with profiles

Robert R. Alfano

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support